Aileen Stockburger

Mrs Stockburger previously was the Worldwide Vice President of Business Development for the DePuy Synthes Group of Johnson & Johnson, where she oversaw the group's merger and acquisition activities, including deal structuring, negotiations, contract design & review, and deal terms. She led Johnson & Johnson's efforts to acquire Synthes for approximately $21 billion. She also led to divest the DePuy Trauma business and acquire Micrus Endovascular. She was also involved in numerous other M&A transactions including Pfizer Consumer Healthcare (US$16.5 billion), Aveeno, BabyCenter, OraPharma, DePuy, DePuy Miket, Kodak Clinical Diagnostics and Neutrogena. She is also a member of Risk Committee.